Navigation Links
Ampersand Acquires Willow Laboratories
Date:11/13/2012

LYNN, Mass., Nov. 13, 2012 /PRNewswire/ -- Willow Laboratories announced today that it has been acquired by Ampersand Capital Partners.  Willow is one of the country's leading clinical and forensic toxicology laboratories providing urine, hair, and saliva testing services to a wide range of healthcare providers including treatment centers, physician practices, and other laboratories.  Using state-of-the-art technology, Willow provides qualitative and quantitative alcohol and drugs-of-abuse test results to aid clients in the diagnosis and treatment of substance abuse.

Gail Marcus has joined Willow as president and chief executive officer.  Ms. Marcus has significant experience building successful healthcare service organizations and was recently CEO of Caris Diagnostics, (now Miraca Life Sciences), a national diagnostic pathology laboratory. 

Ms. Marcus also serves as president and CEO of Calloway Laboratories, which recently signed a definitive agreement to be acquired by Ampersand.  She commented, "I am excited to be working with the Willow and Calloway management teams and look forward to sharing strengths and resources across the companies in order to provide clients the most-complete set of toxicology lab services available in the marketplace."

Jared Bartok, general partner at Ampersand, commented that "Willow is another key piece of our strategy to invest in the multi-billion dollar toxicology lab industry.  With the infusion of additional capital and management resources, Willow is well positioned to capitalize on future growth opportunities in the substance abuse market while implementing a zero tolerance compliance policy." 

About Willow Laboratories 
Willow is a state and federally licensed clinical toxicology lab providing a broad spectrum of testing services for substance abuse rehabilitation providers to aid them in the diagnosis and treatment of drug and alcohol addiction.  Founded in 1995, Willow performs millions of drug tests annually and has clients in 20 states. 

To learn more about Willow, visit www.willowlabs.com

About Ampersand Capital Partners  
Ampersand is a Boston-based private equity firm with a focus on middle market growth equity investments in the Healthcare sector.  Ampersand leverages its unique blend of private equity and operating experience to build value and drive long-term performance alongside its portfolio company management teams.  Ampersand's portfolio has included more than twenty years of successful investments in the specialty laboratory industry.

To learn more about Ampersand, visit www.ampersandcapital.com 


'/>"/>
SOURCE Willow Laboratories
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Johnson & Johnson (China) Investment Ltd. Acquires Guangzhou Bioseal Biotechnology Co., Ltd.
2. Marken Acquires European Kit Building Operation From LabCorp Clinical Trials
3. PLZ Aeroscience Acquires Assured Packaging
4. NeuroSigma Subsidiary Acquires Thin-Film Nitinol Fabrication Patent Portfolio
5. PneumRx, Inc. Acquires Key Assets From Broncus
6. FMC Corporation Acquires Phytone, Ltd., a Leading European Natural Colors Business
7. Frazier Healthcare Acquires U.S. Commercial Pharmaceutical Packaging Operations from Catalent Pharma Solutions
8. RoundTable Healthcare Partners Portfolio Company, Renaissance Acquisition Holdings, LLC Acquires DPT Laboratories
9. ERT Acquires invivodata to Establish the Industrys Most Experienced Provider of Clinical Outcome Assessment Solutions
10. Arthritis Associates of South Florida Acquires Access to Patient Health History Faster with Digital Pen Technology from Anoto and NextGen Healthcare
11. AstraZeneca Acquires Neuroscience Assets From Link Medicine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/7/2017)... , June 7, 2017  Novavax, Inc., (Nasdaq: ... of two Phase 2 trials of its RSV F protein ... child bearing age have been published in the journal ... have been shared in prior scientific conferences). The Company previously ... April 2014. Novavax is developing the RSV F Vaccine with ...
(Date:6/2/2017)... Mass. , June 2, 2017  NxStage Medical, ... renal care, today announced new findings demonstrating positive biochemical ... ® System One™. The data will be presented ... in Madrid, Spain . ... to Improve Home Dialysis Network in Europe ...
(Date:5/29/2017)...  Cellect Biotechnology Ltd. (NASDAQ: APOP ; TASE: ... functional selection of stem cells, today provided a corporate ... ended March 31 st , 2017. ... first quarter of 2017," said Dr. Shai Yarkoni, Chief ... treatment of the first blood cancer patient in the ...
Breaking Medicine Technology:
(Date:6/28/2017)... ... June 28, 2017 , ... The parent company ... in employee engagement. Omaha-based C&A Industries, a national leader in staffing and ... in North America for 2017. The annual award, issued by Achievers, ...
(Date:6/28/2017)... Church, VA (PRWEB) , ... June 28, 2017 , ... ... http://www.fdanews.com/fdaeumdregs      , No matter on which side of the Atlantic devicemakers ... medical device regulations they have to follow. , In addition to the full text ...
(Date:6/28/2017)... ... June 28, 2017 , ... Eating disorders have the highest mortality ... at least one person dies as a direct result from an eating disorder in ... qualified treatment providers. The iaedp Foundation meets this challenge by offering what has become ...
(Date:6/28/2017)... ... June 28, 2017 , ... American Farmer proudly announces the participation of ... winning television series, scheduled to broadcast fourth quarter 2017. American Farmer airs Tuesdays at ... supplier of garden pea seed. As demand grew, the small company located in Moscow, ...
(Date:6/28/2017)... (PRWEB) , ... June 28, 2017 , ... ... insurance management and financial planning assistance to clients in southern Montana, is announcing ... offered by Zoo Montana. , The outreach programs offered by Zoo Montana provide ...
Breaking Medicine News(10 mins):